UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Genexine sets up joint firm in Thailand
Genexine said that it has established KinGen Biotech in Thailand, a joint v...
by Lee Han-soo
|
2019-09-26 17:00
라인
[Analysis] Successive failures throw Korean bioindustry's drug-developing ability into question
The recent failures by Korean biotech companies to reach meaningful results...
by Lee Han-soo
|
2019-09-26 15:39
라인
Pfizer’s leukemia therapy Besponsa to get insurance benefit
The government said it would grant insurance benefit to Pfizer’s leukemia t...
by Kim Yun-mi
|
2019-09-26 11:26
라인
'Xtandi emerges as convenient treatment option for prostate cancer patients'
Astellas Korea is strengthening its position in the local prostate cancer m...
by Lee Han-soo
|
2019-09-25 17:39
라인
Huons, Lipac Oncology to co-develop bladder cancer treatment
Huons said that it has signed an exclusive licensing agreement for developi...
by Lee Han-soo
|
2019-09-25 11:18
라인
AstraZeneca releases detailed results of P3 trial of SGLT2 inhibitor
AstraZeneca announced detailed results of the landmark phase 3 DAPA-HF tria...
by Lee Han-soo
|
2019-09-24 18:08
라인
Qurient enrolls patients for trials of atopy treatment
Qurient said Tuesday that it has completed patient enrollment for phase 2b ...
by Lee Han-soo
|
2019-09-24 17:00
라인
Hanmi’s US partner to unveil results of anticancer drug study
Hanmi Pharmaceutical said that Athenex, its U.S. partner, plans to present ...
by Lee Han-soo
|
2019-09-24 17:00
라인
Why using end-to-end services should be part of a drug product strategy
Specialized services offered by end-to-end service providers are essential ...
by Lee Han-soo
|
2019-09-24 16:54
라인
Helixmith's fails to end P3 trials of diabetic peripheral neuropathy treatment
Helixmith said that it has failed to make conclusions due to data contamina...
by Lee Han-soo
|
2019-09-24 16:38
라인
Hwail, SupexBNP wins patent for neutropenia treatment in US
Hwail Pharmaceutical and SupexBNP said that they have registered a patent f...
by Lee Han-soo
|
2019-09-23 22:34
라인
Drug firms uncertain about pricing of quadrivalent flu vaccines
As the 2019-2020 flu season approaches, pharmaceutical firms are engaging i...
by Jeong Sae-im
|
2019-09-23 14:52
라인
Roche’s Tecentriq becomes 1st immunotherapy to win indication for SCLC
Roche Korea has received approval from the Ministry of Food and Drug Safety...
by Lee Han-soo
|
2019-09-23 13:28
라인
‘Diabetes treatment Forxiga born as new heart drug in DAPA-HF study’
“The DAPA-HF trial results announced in the recent European Society of Card...
by Kim Yun-mi
|
2019-09-23 11:45
라인
‘Daewoong’s diabetes therapy proves superior blood-sugar-lowering effect to existing drugs’
Daewoong Pharmaceutical said its poster session on phase 1 clinical trial o...
by Lee Han-soo
|
2019-09-20 17:51
라인
Dongwha could lose ₩60 billion sales as GSK ends deal
Dongwha Pharmaceutical faces a steep decrease in sales as GSK Consumer Heal...
by Lee Han-soo
|
2019-09-20 14:28
라인
Novo Nordisk releases trial result for basal insulin analog injection
Novo Nordisk said it has presented the global head-to-head trial called CON...
by Lee Han-soo
|
2019-09-20 12:27
라인
Multinational pharmaceuticals continue to increase R&D spending in Korea
The Korea Research-based Pharma Industry Association (KRPIA) said that the ...
by Lee Han-soo
|
2019-09-19 17:15
라인
Hanmi unveils strong diabetes pipeline at EU meet
Hanmi Pharmaceutical said that it has confirmed the global competitiveness ...
by Lee Han-soo
|
2019-09-19 15:30
라인
‘Galderma Korea ran background checks on unionized workers’
The labor union of Galderma Korea, the local offshoot of a skin healthcare ...
by Jeong Sae-im
|
2019-09-19 15:18
-
이전
31
32
33
34
35
36
37
38
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top